Category: Editorial

Repeated low-level red-light therapy: a novel method for myopia prevention and control

Authors: Zhu Zhuoting,  He Mingguang DOI: 10.3760/cma.j.cn115989-20220127-00031 Published 2022-06-10 Cite asChin J Exp Ophthalmol, 2022, 40(6): 487-490. Abstract China has recently proposed a countrywide myopia control strategy for children and adolescents due to the rapidly increasing incidence and early onset of myopia.Recent studies have proposed interventions and methods for myopia prevention and control, such as […]

Development and challenge of human lentoid bodies generation

Authors: Fu Qiuli,  Yao Ke DOI: 10.3760/cma.j.cn115989-20220114-00015 Published 2022-05-10 Cite asChin J Exp Ophthalmol, 2022, 40(5): 385-388. Abstract Organoid is one of the hottest areas of research in the field of stem cells, which is an organ in a dish with three-dimensional structure and physiological functions that are highly similar to organs in vivo.At present, […]

Evolution of cataract surgical techniques and improvement of surgical precision

Authors: Xu Wen,  Xu Zhe DOI: 10.3760/cma.j.cn115989-20210715-00413 Published 2022-05-10 Cite asChin J Exp Ophthalmol, 2022, 40(5): 389-394. Abstract With the increase of aging population, the rising demand for cataract surgery, along with the growing demand for post-operative visual quality, the concept of refractive cataract surgery has been put forward, which places more emphasis on the […]

New paradigms of immune regulation in glaucoma during the whole clinical process

Authors: Wu Jian,  Su Wenru,  Zhuo Yehong DOI: 10.3760/cma.j.cn115989-20220314-00104 Published 2022-04-10 Cite asChin J Exp Ophthalmol, 2022, 40(4): 289-293. Abstract Glaucoma is an irreversible blinding eye disease caused by the structural and functional damage of optic nerve induced by pathological increase of intraocular pressure (IOP), characterized by multiple causes and strong heterogeneity.The control of IOP […]

Attaching importance to the genetic diagnosis of early-onset high myopia

Author: Sheng Xunlun DOI: 10.3760/cma.j.cn115989-20210915-00517 Published 2022-03-10 Cite asChin J Exp Ophthalmol, 2022, 40(3): 193-198. Abstract According to the onset age, high myopia can be divided into late-onset high myopia (loHM) and early-onset high myopia (eoHM). Numerous genetic studies have shown that eoHM is different from loHM.EoHM, a special type of high myopia before school […]

The opportunities of metabolic windows for early diagnosis and precise prevention and treatment of diabetic retinopathy

Authors: Zhang Fang,  Xu Xun DOI: 10.3760/cma.j.cn115989-20211209-00678 Published 2022-01-10 Cite asChin J Exp Ophthalmol, 2022, 40(1): 1-5. Abstract Diabetes mellitus (DM) is a chronic metabolic disease caused by multiple etiologies. Diabetic retinopathy (DR), as a primary ocular complication of DM, is the leading cause of blindness among working-age adults in the world.With the rapid increase […]

Future developments and trends in refractive surgery

Authors: Wang Yan,  Ma Jiaonan DOI: 10.3760/cma.j.cn115989-20210804-00446 Published 2021-12-10 Cite asChin J Exp Ophthalmol, 2021, 39(12): 1025-1030. Abstract Refractive surgery is one of the important methods for refractive error correction, which include corneal refractive surgery and intraocular refractive surgery.In recent years, refractive surgery has a rapid development, and there is still development space and potential […]

Pay attention to the risk of infection and tumor progression during application of TNF-α inhibitors in uveitis

Authors: Chi Ying,  Yang Liu DOI: 10.3760/cma.j.cn115989-20211020-00571 Published 2021-11-10 Cite asChin J Exp Ophthalmol, 2021, 39(11): 929-932. Abstract Adalimumab, one of the tumor necrosis factor-α (TNF-α) inhibitors, has been approved as a therapeutic drug for non-infectious intermediate, posterior and pan-uveitis by FDA.Due to the good efficacy, TNF-α inhibitors are being applied widely in ophthalmology.However, some […]

Focus of glaucoma prevention and control in China at present

Authors: Chen Xueli,  Chen Junyi,  Chen Yuhong,  Sun Xinghuai DOI: 10.3760/cma.j.cn115989-20210420-00267 Published 2021-10-10 Cite asChin J Exp Ophthalmol, 2021, 39(10): 841-844. Abstract The pathogenesis, diagnosis and management of glaucoma are complex and the population with glaucoma is huge in China now.With the development and popularization of cataract surgery, the visual disability and blindness caused by […]

Paying attention to the natural course of disease for a development of gene therapy of inherited retinal diseases

Authors: Wang Fenghua,  Chen Jieqiong,  Sun Xiaodong DOI: 10.3760/cma.j.cn115989-20201007-00677 Published 2021-08-10 Cite asChin J Exp Ophthalmol, 2021, 39(8): 665-669. Abstract Most inherited retinal diseases (IRDs) severely impair vision and lack effective treatments.With the approval of Luxturna, the world’s first gene therapy drug for IRDs in 2017 by the U. S.FDA, gene therapy has brought new […]